Study S002378

PILGRIM - Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus Type II

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02036372
Acronym: PILGRIM
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: COMPLETED
Enrollment: 150
Start: 2014-01
Primary completion: 2017-01
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions: Diabetes Mellitus Type II
Interventions: DRUG:Liraglutide; DRUG:Insulin bolus; DRUG:GIK infusion
Results posted: FALSE

Registered primary outcomes

Median glucose [1 hour after surgery]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0026656	Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes-PILGRIM trial. Polderman JA, BMC anesthesiology	2014	Protocol	PMID 25419179 DOI	cites ClinicalTrials.gov:NCT02036372; registry reference DERIVED:25419179